Drug Trial Radar · NCT06561048
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Oct 2, 2024
Primary completion
Nov 2027
Study completion Dec 2028
Sponsor
- Lead sponsor
- Corvus Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 3, randomized, 2-arm, open-label, multicenter, stratified study of soquelitinib versus physician's choice standard of care (SOC) treatment (selected single agents) in participants with relapsed/refractory (R/R) peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), follicular helper T-cell lymphomas (FHTCLs), or systemic anaplastic large-cell lymphoma (sALCL).
Conditions
- Peripheral T-Cell Lymphoma, Not Otherwise Specified
- Angioimmunoblastic T-cell Lymphoma
- Follicular T-Cell Lymphoma
- Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
- Systemic Anaplastic Large Cell Lymphoma
- Lymphoma, T-Cell, Peripheral
- Lymphoma, T-Cell
Interventions
SoquelitinibDrug
Soquelitinib 200 mg tablets will be taken by mouth two times a day
BelinostatDrug
Belinostat (1000 mg/m2) will be administered by intravenous infusion once daily on Days 1 through 5 of each 21-day cycle
PralatrexateDrug
Pralatrexate (30 mg/m2) will be administered intravenously over 3 to 5 minutes once weekly for 6 weeks in each 7-week cycle
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survivalTime frame: Up to 4 years post study treatment initiation
Locations
37 sites in 3 countries. Site status is shown where the registry gives one.
City of Hope National Medical Center
Duarte, California · Recruiting
University of California, Irvine
Irvine, California · Recruiting
University of California San Francisco
San Francisco, California · Recruiting
Yale University
New Haven, Connecticut · Recruiting
Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine
Miami, Florida · Recruiting
Emory University
Atlanta, Georgia · Recruiting
North Western University Robert H. Lurie Comprehensive Cancer Center RHLCCC
Chicago, Illinois · Recruiting
University of Iowa
Iowa City, Iowa · Recruiting
University of Maryland Medical Center
Baltimore, Maryland · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Roger Cancer Center University of Michigan Health
Ann Arbor, Michigan · Recruiting
Washington University in St. Louis
St Louis, Missouri · Recruiting
Hackensack University Medical Center
Hackensack, New Jersey · Recruiting
Icahn School of Medicine at Mount Sinai
New York, New York · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
Weill Cornell Medicine
New York, New York · Recruiting
North Carolina Cancer Hospital
Chapel Hill, North Carolina · Recruiting
The Ohio State University
Columbus, Ohio · Recruiting
Oregon Health & Science University; Knight Cancer Institute
Portland, Oregon · Recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania · Recruiting
UT Southwestern Medical Center
Dallas, Texas · Recruiting
MD Anderson Cancer Center
Houston, Texas · Recruiting
University of Washington Fred Hutch Cancer Center
Seattle, Washington · Recruiting
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin · Recruiting
St Vincent's Hospital Sydney
Darlinghurst, New South Wales, Australia · Recruiting
St George Hospital
Kogarah, New South Wales, Australia · Recruiting
ICON Cancer Centre
South Brisbane, Queensland, Australia · Recruiting
Royal Adelaide Hospital
Adelaide, South Australia, Australia · Recruiting
Flinders Medical Center
Bedford Park, South Australia, Australia · Recruiting
Royal Hobart Hospital
Hobart, Tasmania, Australia · Recruiting
Box Hill Hospital
Box Hill, Victoria, Australia · Recruiting
Austin Hospital
Heidelberg, Victoria, Australia · Recruiting
Epworth Healthcare
Richmond, Victoria, Australia · Recruiting
Linear Clinical Research
Perth, Western Australia, Australia · Recruiting
BC Cancer Research Institute
Vancouver, British Columbia, Canada · Recruiting
The Ottawa Hospital - General Campus
Ottawa, Ontario, Canada · Recruiting
The Princess Margaret Cancer Centre
Toronto, Ontario, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.